Authors: Ibrahim, NK Valero, V Rahman, Z Theriault, RL Walters, RS Buzdar, AU Booser, DJ Holmes, FA Murray, DJ Willey, J Bast, R Hortobagyi, GN

Citation: Nk. Ibrahim et al., Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation, CANCER INV, 19(5), 2001, pp. 459-466

Authors: Ibrahim, NK Valero, V Theriault, RL Willey, J Walters, RS Buzdar, AU Booser, DJ Hortobagyi, GN

Citation: Nk. Ibrahim et al., Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer, AM J CL ONC, 23(2), 2000, pp. 117-121

Authors: Booser, DJ Walters, RS Holmes, FA Hortobagyi, GN

Citation: Dj. Booser et al., Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatinfor relapsed metastatic breast cancer: A phase II study, AM J CL ONC, 23(1), 2000, pp. 40-41

Authors: Holmes, FA Valero, V Walters, RS Theriault, RL Booser, DJ Gibbs, H Fraschini, G Buzdar, AU Willey, J Frye, D Asmar, L Hortobagyi, GN

Citation: Fa. Holmes et al., Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results, ANN ONCOL, 10(4), 1999, pp. 403-411

Authors: Valero, V Buzdar, AU Theriault, RL Azarnia, N Fonseca, GA Willey, J Ewer, M Walters, RS Mackay, B Podoloff, D Booser, D Lee, LW Hortobagyi, GN

Citation: V. Valero et al., Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, andfluorouracil as first-line therapy in patients with metastatic breast cancer, J CL ONCOL, 17(5), 1999, pp. 1425-1434